AI Portfolio Summary
In 2026 Q1, ACT CAPITAL MANAGEMENT, LLC maintained a portfolio of 78 distinct positions. The most significant new addition to the portfolio was ALUMIS INC, which now represents 3.02% of the total fund value. They heavily accumulated shares in CELCUITY INC, increasing their position by 44.6%. The fund also reduced its exposure to BLOOM ENERGY CORP by 65.4%.
Total Positions
78
Quarter
2026 Q1
Top Holding
KRYS (12.3%)
Top 10 Concentration
73.6%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 78
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
KRYS
KRYSTAL BIOTECH...
|
Healthcare | 12.28% | 12.06% |
#1
Prev: #1
|
6.5 | -23 | -0.0% |
P
S
|
60,477 | $15,622,419 | 2021 Q2 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
CVX
CHEVRON CORP
|
Energy | 12.20% | 9.67% |
#2
Prev: #2
|
6.0 | -3,500 | -4.5% |
P
S
|
75,000 | $15,517,500 | 2021 Q3 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
XOM
EXXON MOBIL COR...
|
Energy | 9.33% | 8.03% |
#3
Prev: #3
|
5.2 | -12,500 | -15.2% |
P
S
|
70,000 | $11,876,200 | 2022 Q2 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
CELC
CELCUITY INC
|
Healthcare | 8.22% | 5.11% |
#4
3
Prev: #7
|
6.3 | 28,260 | 44.6% |
P
S
|
91,675 | $10,463,785 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
TGTX
TG THERAPEUTICS...
|
Healthcare | 6.50% | 6.48% |
#5
Prev: #5
|
3.6 | -19,850 | -7.4% |
P
S
|
249,025 | $8,272,611 | 2021 Q2 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
ABVX
ABIVAX SA
|
Healthcare | 6.20% | 6.97% |
#6
2
Prev: #4
|
4.5 | 7,000 | 11.0% |
P
S
|
70,900 | $7,894,715 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
AMZN
AMAZON.COM INC
|
Consumer Cyclical | 5.40% | 4.59% |
#7
1
Prev: #8
|
4.7 | 8,400 | 34.1% |
P
S
|
33,000 | $6,872,910 | 2021 Q2 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
VKTX
VIKING THERAPEU...
|
Healthcare | 5.35% | 5.86% |
#8
2
Prev: #6
|
2.6 | 3,200 | 1.6% |
P
S
|
209,300 | $6,810,622 | 2021 Q2 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
ARWR
ARROWHEAD PHARM...
|
Healthcare | 4.07% | 4.03% |
#9
1
Prev: #10
|
3.6 | 7,500 | 10.0% |
P
S
|
82,500 | $5,172,750 | 2021 Q2 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
NKTR
NEKTAR THERAPEU...
|
Healthcare | 4.01% | 1.75% |
#10
8
Prev: #18
|
4.1 | 19,700 | 38.5% |
P
S
|
70,900 | $5,101,255 | 2021 Q2 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 3.34% | 3.31% |
#11
Prev: #11
|
2.3 | no change | no change |
P
S
|
64,500 | $4,251,195 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
ALMS
ALUMIS INC
|
Healthcare | 3.02% | — |
#12
Prev: #—
|
4.7 | 174,250 | no change |
NEW
|
174,250 | $3,838,728 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
ET
ENERGY TRANSFER...
|
Energy | 2.02% | 1.77% |
#13
4
Prev: #17
|
1.8 | no change | no change |
P
S
|
133,100 | $2,568,830 | 2022 Q2 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
FCX
FREEPORT-MCMORA...
|
Basic Materials | 1.78% | — |
#14
Prev: #—
|
4.2 | 38,500 | no change |
NEW
|
38,500 | $2,263,030 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
AAOI
APPLIED OPTOELE...
|
Technology | 1.72% | — |
#15
Prev: #—
|
4.2 | 25,900 | no change |
NEW
|
25,900 | $2,190,881 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
XENE
XENON PHARMACEU...
|
Healthcare | 1.53% | — |
#16
Prev: #—
|
4.1 | 33,500 | no change |
NEW
|
33,500 | $1,948,025 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
NUVB
NUVATION BIO IN...
|
Healthcare | 0.98% | 4.42% |
#17
8
Prev: #9
|
0.4 | -320,500 | -52.5% |
P
S
|
290,000 | $1,244,100 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
STAA
STAAR SURGICAL ...
|
Healthcare | 0.82% | 1.04% |
#18
3
Prev: #21
|
1.3 | no change | no change |
P
S
|
55,500 | $1,037,850 | 2021 Q2 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 0.68% | 0.17% |
#19
25
Prev: #44
|
3.3 | 2,000 | 285.7% |
P
S
|
2,700 | $869,913 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
GBTC
GRAYSCALE BITCO...
|
ETF | 0.64% | 1.90% |
#20
6
Prev: #14
|
0.3 | -19,000 | -55.2% |
P
S
|
15,400 | $812,504 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
S
SENTINELONE INC
|
Technology | 0.55% | — |
#21
Prev: #—
|
3.7 | 54,300 | no change |
NEW
|
54,300 | $699,384 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
LITE
LUMENTUM HLDGS ...
|
Technology | 0.50% | — |
#22
Prev: #—
|
3.7 | 900 | no change |
NEW
|
900 | $632,484 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
BE
BLOOM ENERGY CO...
|
Industrials | 0.48% | 0.91% |
#23
1
Prev: #24
|
0.2 | -8,500 | -65.4% |
P
S
|
4,500 | $609,705 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
CRGY
CRESCENT ENERGY...
|
Energy | 0.48% | 0.42% |
#24
11
Prev: #35
|
0.2 | -16,312 | -26.6% |
P
S
|
45,000 | $607,500 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
KURA
KURA ONCOLOGY I...
|
Healthcare | 0.47% | 0.62% |
#25
5
Prev: #30
|
1.2 | no change | no change |
P
S
|
73,900 | $600,807 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
VIR
VIR BIOTECHNOLO...
|
Healthcare | 0.45% | — |
#26
Prev: #—
|
3.7 | 64,300 | no change |
NEW
|
64,300 | $576,128 | 2021 Q4 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
CRCL
CIRCLE INTERNET...
|
Financial Services | 0.45% | — |
#27
Prev: #—
|
3.7 | 6,000 | no change |
NEW
|
6,000 | $572,460 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
HCC
WARRIOR MET COA...
|
Basic Materials | 0.44% | 0.86% |
#28
3
Prev: #25
|
0.2 | -6,000 | -50.0% |
P
S
|
6,000 | $558,900 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
PATH
UIPATH INC
|
Technology | 0.44% | 0.62% |
#29
Prev: #29
|
2.2 | 3,000 | 6.4% |
P
S
|
50,000 | $555,000 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
SRRK
SCHOLAR ROCK HL...
|
Healthcare | 0.42% | 0.43% |
#30
3
Prev: #33
|
0.7 | -1,200 | -10.0% |
P
S
|
10,800 | $530,928 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
WGS
GENEDX HOLDINGS...
|
Healthcare | 0.40% | 0.32% |
#31
5
Prev: #36
|
3.2 | 5,000 | 166.7% |
P
S
|
8,000 | $513,760 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
MU
MICRON TECHNOLO...
|
Technology | 0.40% | — |
#32
Prev: #—
|
3.7 | 1,500 | no change |
NEW
|
1,500 | $506,760 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
NVDA
NVIDIA CORPORAT...
|
Technology | 0.38% | — |
#33
Prev: #—
|
3.7 | 2,800 | no change |
NEW
|
2,800 | $488,320 | 2021 Q2 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
REPL
REPLIMUNE GROUP...
|
Healthcare | 0.37% | 0.48% |
#34
2
Prev: #32
|
1.1 | no change | no change |
P
S
|
61,500 | $470,475 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
RGNX
REGENXBIO INC
|
Healthcare | 0.37% | 0.96% |
#35
12
Prev: #23
|
0.1 | -26,500 | -32.1% |
P
S
|
56,000 | $469,280 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
PALI
PALISADE BIO IN...
|
Healthcare | 0.35% | 0.29% |
#36
1
Prev: #37
|
3.1 | 107,500 | 71.7% |
P
S
|
257,500 | $450,625 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
OLMA
OLEMA PHARMACEU...
|
Healthcare | 0.29% | 1.08% |
#37
18
Prev: #19
|
0.1 | -28,500 | -53.3% |
P
S
|
25,000 | $372,750 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
GLUE
MONTE ROSA THER...
|
Healthcare | 0.29% | — |
#38
Prev: #—
|
3.6 | 22,500 | no change |
NEW
|
22,500 | $370,125 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
ONDS
ONDAS INC
|
Technology | 0.27% | — |
#39
Prev: #—
|
3.6 | 37,500 | no change |
NEW
|
37,500 | $339,000 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
ACOG
ALPHA COGNITION...
|
Healthcare | 0.22% | 0.27% |
#40
2
Prev: #38
|
1.1 | no change | no change |
P
S
|
51,500 | $282,735 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
MBX
MBX BIOSCIENCES...
|
Healthcare | 0.21% | — |
#41
Prev: #—
|
3.6 | 9,000 | no change |
NEW
|
9,000 | $268,650 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
N/A
ARKO PETE CORP
|
—
|
Unknown | 0.21% | — |
#42
Prev: #—
|
3.6 | 15,000 | no change |
NEW
|
15,000 | $268,350 | — | 13F Filing | 2026-03-31 | 2026-05-08 | ||
|
KYTX
KYVERNA THERAPE...
|
Healthcare | 0.20% | 0.19% |
#43
3
Prev: #40
|
2.1 | 4,900 | 19.5% |
P
S
|
30,000 | $258,900 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
RYI
RYERSON HOLDING...
|
Industrials | 0.19% | — |
#44
Prev: #—
|
3.6 | 10,800 | no change |
NEW
|
10,800 | $242,784 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
N/A
TERRA INNOVATUM...
|
—
|
Unknown | 0.16% | 0.17% |
#45
2
Prev: #43
|
1.1 | no change | no change |
P
S
|
45,000 | $208,800 | — | 13F Filing | 2026-03-31 | 2026-05-08 | ||
|
INCY
INCYTE CORP
|
Healthcare | 0.15% | — |
#46
Prev: #—
|
3.6 | 2,000 | no change |
NEW
|
2,000 | $188,240 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
CAPR
CAPRICOR THERAP...
|
Healthcare | 0.12% | 0.04% |
#47
7
Prev: #54
|
3.0 | 3,500 | 233.3% |
P
S
|
5,000 | $152,000 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
VPG
VISHAY PRECISIO...
|
Technology | 0.10% | — |
#48
Prev: #—
|
3.5 | 3,000 | no change |
NEW
|
3,000 | $130,260 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
ESPR
ESPERION THERAP...
|
Healthcare | 0.10% | 0.14% |
#49
4
Prev: #45
|
1.0 | no change | no change |
P
S
|
47,500 | $130,150 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-08 | |||
|
AMLX
AMYLYX PHARMACE...
|
Healthcare | 0.10% | 0.09% |
#50
1
Prev: #49
|
1.0 | no change | no change |
P
S
|
9,000 | $125,100 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-08 |
Showing 1-50 of 78 holdings